-
The Internal Revenue Service warned taxpayers about a new phishing scam targeting Washington, D.C., Maryland and Virginia residents.
April 6 -
The biggest deal in drug industry history is dead. Pfizer Inc. and Allergan Plc terminated their $160 billion merger on Wednesday after the U.S. government proposed regulations to crack down on corporate tax inversions, stymieing New York-based Pfizers long effort to get out from under the highest corporate tax rate in the developed world.
April 6 -
A lot of Americans feel like they're getting cheated at tax time. In a Pew Research Center poll last year, 61 percent said it bothered them "a lot" that "some wealthy people don't pay their fair share."
April 6 -
Jay Nisberg and Gary Shamis, co-authors of the book "Stratagem," talk about what to expect from strategic planning meetings for accounting firms, how long they can take and how to synthesize them.
April 5 -
CPAs can claim a free smoothie named, appropriately enough, The CPA, from the Banana Smoothies & Frozen Yogurt chain on April 17 and 18 for surviving another tax season.
April 5 -
President Barack Obama issued a forceful denunciation of companies that shield profit overseas through corporate inversions, praising new rules that would curb what he called one of the U.S. tax systems most insidious loopholes.
April 5 -
Accounting and consulting firm Rosen, Sapperstein & Friedlander, LLC has acquired SHR Associates, Inc., a regional health care consulting firm based in Annapolis, Md.
April 5 -
A former U.S. Tax Court judge and her husband have been indicted for conspiracy to commit tax evasion and obstruction of an Internal Revenue Service audit.
April 5 -
Panama and the U.S. have at least one thing in common: Neither has agreed to new international standards to make it harder for tax evaders and money launderers to hide their money.
April 5 -
As the U.S. took tougher steps Monday to limit the tax-cutting power of corporate inversions, analysts said the new rules may put a planned $160 billion merger between Pfizer Inc. and Allergan Plc in jeopardy.
April 5
